Recent

% | $
Quotes you view appear here for quick access.

Marathon Petroleum Corporation Message Board

  • todlondon todlondon Feb 15, 2013 8:27 PM Flag

    Several Major Analyts have raised their estimates

    Marathon Petroleum (NYSE: MPC) had its price target raised by Deutsche Bank from $72.00 to $90.00 in a research note released on Monday morning. They currently have a hold rating on the stock.
    Marathon Petroleum traded up 0.96% on Monday, hitting $81.67. Marathon Petroleum has a 52-week low of $33.65 and a 52-week high of $82.50. The stock’s 50-day moving average is currently $68.42. The company has a market cap of $27.701 billion and a price-to-earnings ratio of 8.18.
    The company also recently declared a quarterly dividend, which is scheduled for Monday, March 11th. Stockholders of record on Wednesday, February 20th will be given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date of this dividend is Friday, February 15th.
    Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet reiterated a hold rating on shares of Marathon Petroleum in a research note to investors on Tuesday, February 5th. Separately, analysts at Oppenheimer raised their price target on shares of Marathon Petroleum from $65.00 to $90.00 in a research note to investors on Tuesday, February 5th. They now have a perform rating on the stock. They noted that the move was a valuation call. Finally, analysts at Barclays Capital raised their price target on shares of Marathon Petroleum from $100.00 to $120.00 in a research note to investors on Thursday, January 31st. They now have an overweight rating on the stock.
    Eleven investment analysts have rated the stock with a buy rating, three have given an overweight rating, and five have issued a hold rating to the company. The company presently has an average rating of overweight and an average price target of $82.88.

 
MPC
41.97+0.04(+0.10%)Aug 24 4:02 PMEDT